UMG repeats one AI formula across separate company deals

The audio task

An artist, manager or partner company wants to know what standard Universal Music Group holds itself to before licensing catalogue into an AI product, separate from the specific terms of any one settlement or deal UMG has struck with a generative-AI company.

What the documents show

UMG's own October 2024 announcement of its framework collaboration with KLAY states the companies share "the conviction that state-of-the-art foundational AI models are best built and scaled responsibly" and that models must be "ethically and fully respectful of copyright, as well as name and likeness rights," explicitly stating KLAY "will not compete with artists' catalogs in traditional music services." Nearly two years later, UMG's own September 2026 announcement of its ElevenLabs agreement states the deal "reflects the companies' shared commitment to the principles that AI-enabled music innovation should be built responsibly, respect human artistry, and enable artists and songwriters to share in the value created." The same three-part formulation – responsible development, respect for human artistry, shared value for artists – appears in both releases, each tied to a different named AI partner and product.

Rights status

Both documents are UMG's own characterizations of its negotiating posture, not court filings or settlement terms. Neither states that these principles are contractually binding on UMG in general, only that each named deal was built to reflect them. Neither release discloses royalty structures, and neither should be read as describing the terms of any UMG litigation or settlement with a generative-AI company not named in these two announcements.

What to check before you use it

This is an editorial checklist. Before citing "UMG's AI principles" as a fixed policy, confirm whether the claim rests on this recurring press-release language or on an actual signed agreement's text; check whether the deal under discussion is one of the ones UMG has named; and watch for whether a newer announcement restates, narrows or drops this formulation.

• Is this UMG's own stated language for a specific deal, or a broader inference drawn from it?
• Does the announcement I'm relying on name the company and product I actually care about?
• Would UMG's litigation or settlement activity elsewhere change how these principles apply here?

UMG has repeated a consistent three-part formula across at least two years of AI announcements, which is evidence of a stated position, not proof that every UMG partnership meets it in practice.